These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7993463)

  • 1. Somatostatin in gastroenterology. More studies needed.
    Carlson GL; Scott NA; Irving MH; Sancho JJ; Sitges-Serra A
    BMJ; 1994 Sep; 309(6954):604-5. PubMed ID: 7993463
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.
    Kocak S; Bumin C; Karayalcin K; Alacayir I; Aribal D
    Dig Dis; 1994; 12(1):62-8. PubMed ID: 8200125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of octreotide in the treatment of postoperative enterocutaneous fistula].
    Sleth JC; Andraos Y; Borie F; Dumay R; Legroux P
    Ann Fr Anesth Reanim; 1994; 13(5):738-40. PubMed ID: 7733526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of postoperative cutaneointestinal fistula responding to somatostatin analog, with a special reference to serum level of gastrointestinal hormones].
    Katamura H; Ohki S; Sugita A; Ishihara S; Yamamoto M; Sugiyama M
    Nihon Shokakibyo Gakkai Zasshi; 1994 May; 91(5):1037-41. PubMed ID: 8196198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition].
    Hernández-Aranda JC; Gallo-Chico B; Flores-Ramírez LA; Avalos-Huante R; Magos-Vázquez FJ; Ramírez-Barba EJ
    Nutr Hosp; 1996; 11(4):226-9. PubMed ID: 8962902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are somatostatin analogues (octreotide and lanreotide) effective in promoting healing of enterocutaneous fistulas?
    Gray M; Jacobson T
    J Wound Ostomy Continence Nurs; 2002 Sep; 29(5):228-33. PubMed ID: 12510468
    [No Abstract]   [Full Text] [Related]  

  • 7. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
    Scott NA; Finnegan S; Irving MH
    Acta Gastroenterol Belg; 1993; 56(3-4):266-70. PubMed ID: 8266769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V; Felekis D; Zorbalas A
    Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 11. [Post-nephrectomy duodeno-cutaneous fistula resolved with parenteral nutrition and octreotide (somatostatin analogue)].
    Batista Miranda JE; Solé Balcells FJ; Peñalba F; Mayoral J
    Arch Esp Urol; 1994 Oct; 47(8):810-2. PubMed ID: 7818305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complicated enterocutaneous fistulas: failure of octreotide to improve healing.
    Alvarez C; McFadden DW; Reber HA
    World J Surg; 2000 May; 24(5):533-7; discussion 538. PubMed ID: 10787072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide.
    Büyükyavuz I; Karnak I; Yiğit S; Tanyel FC
    Turk J Pediatr; 2004; 46(3):289-91. PubMed ID: 15503489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites.
    Grauer L; Barkin JS
    Digestion; 1994; 55 Suppl 1():24-8. PubMed ID: 7907566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
    Sancho JJ; di Costanzo J; Nubiola P; Larrad A; Beguiristain A; Roqueta F; Franch G; Oliva A; Gubern JM; Sitges-Serra A
    Br J Surg; 1995 May; 82(5):638-41. PubMed ID: 7613936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide and gastrointestinal fistulae.
    Scott NA; Finnegan S; Irving MH
    Digestion; 1990; 45 Suppl 1():66-70; discussion 70-1. PubMed ID: 2185968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
    Jenkins SA; Javle P; Parsons KF; Balan KK; Berein A
    Br J Surg; 1995 Nov; 82(11):1576. PubMed ID: 8535820
    [No Abstract]   [Full Text] [Related]  

  • 18. Causes and management of postoperative enterocutaneous fistulas.
    Memon AS; Siddiqui FG
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):25-8. PubMed ID: 14764257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data.
    Hesse U; Ysebaert D; de Hemptinne B
    Gut; 2001 Dec; 49 Suppl 4(Suppl 4):iv11-21. PubMed ID: 11878789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterocutaneous fistula: are treatments improving?
    Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
    Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.